Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize...
We invest in innovative private early- to mid-stage human Life Science companies that address important medical needs with novel technologies or products backed by compelling science and with differentiated advantages over current treatment options. Our focus is on...
We support the builders of critical Web3 infrastructure. We help design products, protocols, and tokens. We are technical and hands-on investors with roots in Europe.
Smart money for smart innovators" BAS, Business Angels Switzerland, is the most experienced Business Angel Club in Switzerland. We're a not-for-profit organization with chapters in Suisse Romande and in Zürich. We organize 20 events and 60 startup presentations per...
Privilège Ventures is a Swiss-based Venture Capital firm, authorized by the Swiss Financial Market Supervisory Authority (FINMA, www.finma.ch) as venture capital asset manager, investing in promising early-stage startups. With offices in Lugano and Zurich, we aim to...
Maximon empowers entrepreneurs to build impactful, science-based and scalable companies providing healthy aging and rejuvenation solutions. As a company builder, we identify the most promising business opportunities in the field of longevity and build companies from...
At Tomahawk.VC we are building the world's most transparent venture capital firm because we want to be the founders we always wished we had. We know what it's like to sit on the other side of the deal table and how essential communication is to focus and efficiency....
BlueOcean Ventures invests in early stage medical device and life science companies. Unlike other funds the four Founders of BlueOcean Ventures, Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz and Thomas Zehnder, have a long-standing track record in building,...
The New Frontiers (TNF) is an international investment firm headquartered in Geneva, Switzerland with an office at the Dubai International Financial Center (DIFC) and has investments and interests across the globe. We are a focused team of recognised experts searching...
The Quan Funds are a family of absolute-return funds. Our flagship fund, the Quan Technology Fund, is a crossover fund investing in private and public technology companies. The Fund is open-ended, providing quarterly liquidity to investors based on the Fund’s liquid...